Please sign in to follow a disease.

HER2-positive tumors

Clinical trials for HER2-positive tumors explained in plain language.

Never miss a new study

Get alerted when new HER2-positive tumors trials appear

Sign up with your email to follow new studies for HER2-positive tumors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental HER2 cancer drug trial halted early

Disease control Stopped early

This was an early-phase study testing a new drug called XMT-2056 in people with advanced solid tumors that have a protein called HER2. The trial aimed to find a safe dose and check for side effects. It was terminated early, so the full results are not available.

Matched conditions: HER2-POSITIVE TUMORS

Phase 1 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

HER2-positive tumors

Get alerted when new HER2-positive tumors trials appear

Experimental HER2 cancer drug trial halted early